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a total of 474, 456, 443, 421, and 370 subjects completed the
1st, 2nd, 3rd, 4th, and 5th yr study, respectively. At the end
of each year, samples were analyzed from those subjects with
protocol-deﬁned HBV DNA breakthrough (increase ≥ 1.0 log10
copy/ml from the treatment nadir) for the rtN236T or rtA181V
ADV mutations associated with in vitro ADV resistance. ADV was
associated with a low rate of resistance, cumulative rate of 0%
after 1 year,1.3% after 2 years, 5.4% after 3 years and 10.4% after
4 years, 14.6% after 5 years.
Our data showed that treatment with ADV in Chinese HBeAg
positive CHB subjects for up to 5 years resulted in a cumulative
rate of 14.6% (70/480) ADV resistance-associated mutations with
HBV DNA breakthrough.
Concurrent Session 10 – Use and Abuse of Antibiotics
CS10-01 The Role of Infectious Disease Physician in the
Rational Use of Antibiotics
Yonghong Xiao*. First Hospital, Peking University, Beijing, China
Antibacterial agents are the most common used drug in daily clin-
ical practice, in which the wide application and high requirement
for professional capability often leads irrational prescription.
The professionals are urgent need for promoting antibiotic use.
Infectious disease physicians should take the key role in the work
because:
1. Infectious doctors holding professional priority:
a. One of the responsibilities endue with infectious doctor is
therapy of infections;
b. Antibiotic is the major therapeutic measure for infectious
doctor;
c. Infectious doctors are familiar with all the basic infor-
mation related with infection and chemotherapy, such as
bacteriology, virology and antibiotics;
d. Infectious doctors are in the center for contacting pharma-
cist, microbiologist and nosocomial infection controller.
2. Infectious doctors should do following effect to conduct the
work well:
a. Afﬂuent experience in diagnosis and treatment of infec-
tious diseases;
b. Substantial basic medical knowledge, such as epidemiol-
ogy, bacteriology, pathogenesis, pathology, etc;
c. Catching up with new information concerning with their
occupation, such as bacterial resistance, new antibacterial
therapeutic strategy, etc;
d. Familiar with all the information of antibacterial agents,
such as pharmacodynamics, pharmacokinetics, dosing, side
effect, indications, etc.
3. Infectious doctors should take the role by:
a. Collaboration with their clinical co-workers in other ﬁelds;
b. Collaboration with pharmacist, microbiologist and hospital
manager;
c. Active participation for clinical consulting;
d. Personal professional improvement;
e. Holding education and training in hospital about antibac-
terial rational use;
f. Conducting clinical and basic researches.
CS10-02 Antibiotic and Antifungal Resistance in
Antibiotic “Free” Environment
V. Krcmery*, E. Kalavsky. St. Elizabeth University College of
Health and Social Sciences, Laboratory of Tropical Diseases,
Slovakia
It is widely accepted that in community antibiotic/antifungal
resistance is related with consumption. One of the arguments
“pro” is reversibility of resistance which happens frequently in
hospital but was detected also in the community level in at least
3 countries (Denmark, Iceland and Finland).
As every rule is conﬁrmed by an exception, here are several
examples of antimicrobial resistance in regions with no or very
little antimicrobial pressure. We have observed and published
data on absence of resistance to penicillin, oxacillin and ery-
thromycin in S. pneumoniae and S. aureus in an area isolated 21
years by civil war in southern Sudan with no communication, no
health infrastructure and no antimicrobial drugs on the market
however among the same patients 80% tetracycline resistance in
viridans streptococci was observed.
We have observed 66-75% ceftazidim resistance in Enterobacter
spp. Isolated from Cambodian HIV positive children living in
rural areas where no antibiotic drugs are accessible. Last year
a report on high quinolone resistance in E. coli from indigenous
Indian population in rural Bolivia was published by Bartoloni et
al. Similar situation was observed among inhabitants of very
isolated villages from Amazon basin in Peru and Bolivia. Shahum
et al. described 8 children infected with voriconazol resistant
Candida spp. strains from rain forest rural area of Cambodia
near Viet Nam border. Those children and their parents never
received according to patient’s history and medication for years.
Other two similar observations are coming from Nepal and French
Guyana. Those at least 7 reports does no weak our conclusion
that consumption of antibiotics is a major driver of antimicrobial
resistance in the community. However ﬁndings from southern
Sudan, Cambodia, Peru and Bolivia indicate that other factors
promoting antimicrobial resistance in absence of antimicrobial
pressure should be studied as well.
CS10-03 Antibiotic Resistance and the Role of Antibiotic
Stewardship
Victor Lim*. International Medical University, Kuala Lumpur,
Malaysia
The discovery of antibiotics is one of the most signiﬁcant event
in medical history. Antibiotics have added a decade to the aver-
age life expectancy. Together with vaccination, clean water and
other public health measures, mortality from infectious diseases
was dramatically reduced. There was great optimism in the
1950s and 1960s that infectious diseases were no longer a major
challenge. Unfortunately this optimism was unfounded due to
various reasons including the emergence of antibiotic resistance.
Resistance is not new. Sir Alexander Fleming, the discoverer of
penicillin said in his Nobel Prize Address in 1945 that, “It is not
difﬁcult to make microbes resistant to penicillin in the laboratory
by exposing them to concentrations not sufﬁcient to kill them,
and the same thing has occasionally happened in the body.”
The resistome is the collection of all the antibiotic resis-
tance genes and their precursors both in pathogenic and non-
pathogenic bacteria. Studies of the soil resistome has revealed
antibiotic resistant genes to a wide variety of antibiotics in-
cluding synthetic compounds like quinolones and newer antimi-
crobials like Synercid and daptomycin despite no known prior
exposure to these antibiotics or their analogues. The develop-
ment of antimicrobial resistance had therefore been going on in
nature long before antibiotics came into medicinal use. A recent
study has also shown that bacteria can subsist on antibiotics as
their sole carbon source. The soil resistome therefore constitute
an unappreciated reservoir that can contribute to increasing
resistance in pathogenic bacteria
Antibiotic resistance is a major challenge world-wide. It occurs in
gram positive as well in gram negative organisms and in health-
care associated as well as in community acquired infections. In
the last two decades only 2 new classes of anti-bacterials (the
oxazolidinones and the lipopeptides) have been introduced for
clinical use. The situation is now so dire that some physicians
have predicted that there will not be any effective antibiotics to
treat seriously ill patients in the near future.
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There is a close association between overuse of antibiotics and
emergence of resistance. Surveys worldwide point to a high
prevalence of inappropriate antibiotic use both in hospital based
or community based studies. Inappropriate use is common in
developed as well as developing countries. Overuse of antibiotics
exerts a selection pressure hence changing a largely susceptible
population of organisms to a largely resistant one. Although
antibiotic resistance has a ﬁtness cost, compensatory mutations
can mitigate this ﬁtness cost.
Stewardship is the careful and responsible management of some-
thing entrusted to one’s care. Antibiotic stewardship is now an
important public health function as antibiotic resistance has
become one of the most important clinical challenges today.
Antibiotic stewardship should be practiced at international, na-
tional and institutional levels. At the international level the
World Health Organisation has played a key role in encouraging
all countries to adopt national strategies to contain antibiotic re-
sistance. A national strategy should be a multi-faceted approach
which includes strengthening antibiotic resistance surveillance,
developing and implementing antibiotic guidelines for practi-
tioners, improving access to and upgrading the quality of mi-
crobiological diagnostic facilities, increasing public awareness of
antibiotic resistance and controlling and regulating the use of
antibiotics for both medicinal and non-medicinal purposes.
In Malaysia the Ministry of Health has established a fairly well de-
ﬁned administrative structure for the purpose of antibiotic stew-
ardship. The National Infection and Antibiotic Control Committee
is chaired by the Director General of Health. A National Antibi-
otic Resistance Surveillance System was established in 1990. The
monitoring of antibiotic utilization is also undertaken and two
National Medicines Use surveys has thus far been completed.
Monitoring of antibiotic utilisation in the Ministry of Health state
hospitals is focused on 4 major groups of compounds namely
cephalosporins, carbapenems, quinolones and glycopeptides.
At the institutional level all government hospitals have antibi-
otic formularies and guidelines. However the effectiveness of
antibiotic stewardship at an institution depends very much on
the presence of “champions”. In the private sector doctors can
use any product so long as it is registered by the Drug Control
Authority and consultants operate as independent contractors in
private hospitals. Professional societies also issue practice guide-
lines from time to time but the effectiveness of these guidelines
is questionable.
Other measures in antibiotic stewardship would be the legislative
control of prescription and sales of antibiotics for medicinal use
as well as non-medicinal use and the regulation of marketing and
promotional activities by pharmaceutical companies.
The emergence of resistance is threatening the usefulness of
antibiotics and there is an urgent need to conserve this precious
resource. Antibiotic stewardship is crucial to contain resistance.
A concerted effort employing a multifaceted strategy is essen-
tial at international, national and institutional levels and all
stakeholders need to work together to meet this challenge.
CS10-04 Problems with Empirical Antibiotics in Febrile
Neutropenia
B.H. Tan*. Department of Internal Medicine, Singapore General
Hospital, Singapore
Over the years, numerous well-conducted randomized controlled
trials have provided much information guiding the empirical
use of antibiotics in febrile antibiotics. Monotherapy with cef-
tazidime, cefepime, imipenem or meropenem is well supported
by the data, and is in common use. At the same time, the more
traditional combination of an anti-pseudomonal beta-lactam
with an aminoglycoside continues to be used.
Problems with these approaches have arisen largely because of
rising antibiotic resistance. Outbreaks of metallo-betalactamase
(MBL)-producing organisms have occured in Haematology-
Oncology units, as have outbreaks of vancomycin-resistant en-
terococci (VRE) and Stenotrophonomas maltophilia. These out-
breaks have been attributed in part to the overuse of antibiotics.
There are also problems associated with individual drugs, such
as the purported increase in mortality associated with cefepime
use, the link between piperacillin-tazobactam and false-positive
galactomannan readings, and the link between ceftazidime and
the extended-spectrum beta-lactamases (ESBLs).
These topics will be reviewed in the talk.
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CS11-01 Molecular Epidemiological Study of HIV-1
CRF01_AE Transmission in Hong Kong
Wing Cheong Yam*. Department of Microbiology, Queen Mary
Hospital, The University of Hong Kong, Hong Kong SAR, China
A total of 465 HIV-1 CRF01_AE pol sequences were collected for
phylogentic study by the Bayesian coalescent method. CRF01_AE
patient population included 363 males (78.1%) and 102 females
(21.9%) while 65% (314/465) were local Chinese. Major trans-
mission routes were heterosexual contact (63%), followed by
intravenous drug use (19%) and men having sex with men (MSM)
(17%). From phylogenetic analysis, local CRF01_AE strains were
from multiple origins with 3 separate transmission clusters iden-
tiﬁed. Cluster 1 consisted mainly of Chinese male intravenous
drug users (IDU) and heterosexual. Cluster 2 and 3 included
mainly local Chinese MSM and non-Chinese Asian IDUs respec-
tively. Chinese reference isolates available from China (Fujian,
Guangxi, or Liaoning) were clonally related to our transmission
clusters, demonstrating the epidemiological linkage of CRF01_AE
infections between Hong Kong and China. The 3 individual lo-
cal transmission clusters were estimated to have initiated since
late-80s and late-90s, causing subsequent epidemics in the early-
2000s. This is the ﬁrst comprehensive molecular epidemiological
study of HIV-1 CRF01_AE in Hong Kong. It revealed MSM contact
is becoming a major route of local CRF01_AE transmission in
Hong Kong. Epidemiological linkage of CRF01_AE between Hong
Kong and China observed in this study indicates the importance
of regular molecular epidemiological surveillance for the HIV-1
epidemic in our region.
CS11-02 Clinical Retrospective Study of Haemophilia A
Patients with AIDS after Long Term HAART
Hongzhou Lu*. Division of Infectious Diseases, Fudan University,
Shanghai, China
Objcetive: To observe and evaluate the impact of long term
highly active antiretroviral therapy (HAART) in Haemophilia A
patients complicated with AIDS (Haemophilia A/AIDS).
Method: 39 Haemophilia A/AIDS patients undergone HAART for
6 years between 1 June 2002 and 31 July 2008 were enrolled.
The data of Haemophilia A/AIDS patients’ consultation times
(times/year), bleeding times (times/year), VIII factor transfusion
times (times/year), amount of VIII factor transfusion (U/year)
and VIII:C level were analyzed to evaluate haemorrhage status;
grade scales were designed to measure the joint function and
physical ability. Then the data of HIV virus load and CD4+ cells
count were also observed to evaluate the effect of HAART on
immune recovery; ﬁnally, the data of complete blood cell count,
hepatic panel, blood lipid assay, renal function, plasma glucose,
uric acid and blood amylase were also observed to evaluate side
effect of long term HAART.
Results: After 6 years of HAART, no obvious change could be seen
in Haemophilia A/AIDS patients’ mean consultation times, mean
bleeding times, mean VIII factor transfusion times and mean
amount of VIII factor transfusion (P>0.05), only one case exhib-
